Karyopharm Therapeutics
KPTI
KPTI
143 hedge funds and large institutions have $347M invested in Karyopharm Therapeutics in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.29% less ownership
Funds ownership: 5.07% → 4.78% (-0.29%)
55% less call options, than puts
Call options by funds: $4.62M | Put options by funds: $10.3M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
143
Holding in Top 10
–
Calls
$4.62M
Puts
$10.3M
Top Buyers
| 1 | +$9.78M | |
| 2 | +$3.75M | |
| 3 | +$3.01M | |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$1.93M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.79M |
Top Sellers
| 1 | -$16.1M | |
| 2 | -$5.32M | |
| 3 | -$4.21M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$3.82M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$2.92M |